IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WESAM F BALLOUK

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1841291762
CMS profile
1310359
Location
MEMPHIS, TN

General Payments · PY2018–2024

$5,555.76

  • Reported across 245 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,047.66

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology TN All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,038.42 46
Education $9.24 3

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Bayer HealthCare Pharmaceuticals Inc. $271.99 10
Fresenius USA Marketing, Inc. $238.02 14
Mallinckrodt Hospital Products Inc. $170.53 6
NOVARTIS PHARMACEUTICALS CORPORATION $82.06 3
Ardelyx, Inc. $64.07 3
Aurinia Pharma U.S., Inc. $63.60 3
AKEBIA THERAPEUTICS INC $50.93 3
Retrophin, Inc. $39.54 4
Otsuka America Pharmaceutical, Inc. $25.97 1
CorMedix Inc. $20.78 1
CALLIDITAS THERAPEUTICS US INC. $20.17 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $592.95 22
PY2019 $567.58 24
PY2020 $475.99 20
PY2021 $633.98 38
PY2022 $1,153.63 50
PY2023 $1,083.97 42
PY2024 $1,047.66 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $15.25 05/29/2024 Food and Beverage Undisputed 01/23/2026 1145827998 CMS
AKEBIA THERAPEUTICS INC $16.73 08/07/2024 Food and Beverage Undisputed 01/23/2026 1145828554 CMS
AKEBIA THERAPEUTICS INC $18.95 11/26/2024 Food and Beverage Undisputed 01/23/2026 1145831653 CMS
Ardelyx, Inc. $14.97 02/28/2024 Food and Beverage Undisputed 01/23/2026 1146670315 CMS
Ardelyx, Inc. $28.97 06/18/2024 Food and Beverage Undisputed 01/23/2026 1146670317 CMS
Ardelyx, Inc. $20.13 11/05/2024 Food and Beverage Undisputed 01/23/2026 1146670319 CMS
Aurinia Pharma U.S., Inc. $22.37 02/27/2024 Food and Beverage Undisputed 01/23/2026 1150676097 CMS
Aurinia Pharma U.S., Inc. $27.84 04/02/2024 Food and Beverage Undisputed 01/23/2026 1150676099 CMS
Aurinia Pharma U.S., Inc. $13.39 11/22/2024 Food and Beverage Undisputed 01/23/2026 1150676101 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.41 01/23/2024 Food and Beverage Undisputed 01/23/2026 1086194640 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.88 02/14/2024 Food and Beverage Undisputed 01/23/2026 1086142359 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.12 03/12/2024 Food and Beverage Undisputed 01/23/2026 1086178748 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.21 05/21/2024 Food and Beverage Undisputed 01/23/2026 1086175306 CMS
Bayer Healthcare Pharmaceuticals Inc. $110.42 05/25/2024 Food and Beverage Undisputed 01/23/2026 1086122824 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.80 08/13/2024 Food and Beverage Undisputed 01/23/2026 1086147675 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.29 09/10/2024 Food and Beverage Undisputed 01/23/2026 1086131252 CMS
Bayer Healthcare Pharmaceuticals Inc. $7.29 10/22/2024 Food and Beverage Undisputed 01/23/2026 1086087479 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.57 10/22/2024 Food and Beverage Undisputed 01/23/2026 1086145425 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.00 11/12/2024 Food and Beverage Undisputed 01/23/2026 1086185394 CMS
CALLIDITAS THERAPEUTICS US INC. $20.17 09/17/2024 Food and Beverage Undisputed 01/23/2026 1141522135 CMS
CorMedix Inc. $20.78 12/18/2024 Food and Beverage Undisputed 01/23/2026 1082022803 CMS
Fresenius USA Marketing, Inc. $23.69 01/22/2024 Food and Beverage Undisputed 01/23/2026 1154198052 CMS
Fresenius USA Marketing, Inc. $18.52 02/06/2024 Food and Beverage Undisputed 01/23/2026 1154198038 CMS
Fresenius USA Marketing, Inc. $4.94 02/06/2024 Food and Beverage Undisputed 01/23/2026 1154208934 CMS
Fresenius USA Marketing, Inc. $23.49 02/19/2024 Food and Beverage Undisputed 01/23/2026 1154198048 CMS
Fresenius USA Marketing, Inc. $23.18 03/05/2024 Food and Beverage Undisputed 01/23/2026 1154198046 CMS
Fresenius USA Marketing, Inc. $18.19 04/15/2024 Food and Beverage Undisputed 01/23/2026 1154198036 CMS
Fresenius USA Marketing, Inc. $23.67 05/20/2024 Food and Beverage Undisputed 01/23/2026 1154198050 CMS
Fresenius USA Marketing, Inc. $0.90 05/20/2024 Food and Beverage Undisputed 01/23/2026 1154208930 CMS
Fresenius USA Marketing, Inc. $20.76 07/01/2024 Food and Beverage Undisputed 01/23/2026 1154198040 CMS
Fresenius USA Marketing, Inc. $17.72 08/19/2024 Food and Beverage Undisputed 01/23/2026 1154208936 CMS
Fresenius USA Marketing, Inc. $17.92 08/27/2024 Food and Beverage Undisputed 01/23/2026 1154198034 CMS
Fresenius USA Marketing, Inc. $21.15 09/16/2024 Food and Beverage Undisputed 01/23/2026 1154198044 CMS
Fresenius USA Marketing, Inc. $2.83 09/16/2024 Food and Beverage Undisputed 01/23/2026 1154208932 CMS
Fresenius USA Marketing, Inc. $21.06 12/09/2024 Food and Beverage Undisputed 01/23/2026 1154198042 CMS
Mallinckrodt Hospital Products Inc. $21.03 01/30/2024 Food and Beverage Undisputed 01/23/2026 1145048577 CMS
Mallinckrodt Hospital Products Inc. $27.26 03/19/2024 Food and Beverage Undisputed 01/23/2026 1145048579 CMS
Mallinckrodt Hospital Products Inc. $39.95 05/07/2024 Food and Beverage Undisputed 01/23/2026 1145048581 CMS
Mallinckrodt Hospital Products Inc. $22.45 08/20/2024 Food and Beverage Undisputed 01/23/2026 1145048583 CMS
Mallinckrodt Hospital Products Inc. $36.83 10/08/2024 Food and Beverage Undisputed 01/23/2026 1145048585 CMS
Mallinckrodt Hospital Products Inc. $23.01 12/10/2024 Food and Beverage Undisputed 01/23/2026 1145048587 CMS
Novartis Pharmaceuticals Corporation $24.51 04/10/2024 Food and Beverage Undisputed 01/23/2026 1086754245 CMS
Novartis Pharmaceuticals Corporation $29.42 11/14/2024 Food and Beverage Undisputed 01/23/2026 1086754301 CMS
Novartis Pharmaceuticals Corporation $28.13 12/06/2024 Food and Beverage Undisputed 01/23/2026 1086754305 CMS
Otsuka America Pharmaceutical, Inc. $25.97 06/11/2024 Food and Beverage Undisputed 01/23/2026 1118857885 CMS
Travere Therapeutics, Inc. $3.08 01/29/2024 Education Undisputed 01/23/2026 1149904182 CMS
Travere Therapeutics, Inc. $3.08 04/30/2024 Education Undisputed 01/23/2026 1149904186 CMS
Travere Therapeutics, Inc. $3.08 07/09/2024 Education Undisputed 01/23/2026 1149904190 CMS
Travere Therapeutics, Inc. $30.30 10/15/2024 Food and Beverage Undisputed 01/23/2026 1149904194 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.